MEG3 long noncoding RNA regulates the TGF-β pathway genes through formation of RNA–DNA triplex structures

Abstract

Long noncoding RNAs (lncRNAs) regulate gene expression by association with chromatin, but how they target chromatin remains poorly understood. We have used chromatin RNA immunoprecipitation-coupled high-throughput sequencing to identify 276 lncRNAs enriched in repressive chromatin from breast cancer cells. Using one of the chromatin-interacting lncRNAs, MEG3, we explore the mechanisms by which lncRNAs target chromatin. Here we show that MEG3 and EZH2 share common target genes, including the TGF-β pathway genes. Genome-wide mapping of MEG3 binding sites reveals that MEG3 modulates the activity of TGF-β genes by binding to distal regulatory elements. MEG3 binding sites have GA-rich sequences, which guide MEG3 to the chromatin through RNA–DNA triplex formation. We have found that RNA–DNA triplex structures are widespread and are present over the MEG3 binding sites associated with the TGF-β pathway genes. Our findings suggest that RNA–DNA triplex formation could be a general characteristic of target gene recognition by the chromatin-interacting lncRNAs.

Long noncoding RNA Tug1 regulates mitochondrial bioenergetics in diabetic nephropathy

“…Recently, ChIRP-seq and similar approaches have been used to demonstrate that lncRNAs are able to physically bind DNA in a genome-wide fashion, partly through the presence of AG-purine-rich stretches acting as putative lncRNA-binding motifs (30,53). In our own ChIRP-seq analysis, we found that ChIP-qPCR analysis of PGC-1α in control WT (Ctrl) and Tug1-KD cells at the upstream TBE element, an intergenic region devoid of the predicted PGC-1α interaction, and the Ppargc1a gene promoter (primers spanning the distal, medial, and proximal regions of the promoter).…”

Non-coding RNAs: long non-coding RNAs and microRNAs in endocrine-related cancers

“…MEG3 modulates the activity of TGF-β genes by binding to distal regulatory elements forming an RNA-DNA triplex and interacts with the PRC2 complex (Mondal, et al 2015). PCAT1 is the most highly upregulated lncRNA in PCa (Alahari et al 2016).…”

Long non-coding RNA MALAT1 is upregulated and involved in cell proliferation, migration and apoptosis in ovarian cancer

“…Similarly, the lncRNA Linc00617 has been found to have oncogenic activity in breast cancer (10). Furthermore, oncogenic lncRNA maternally expressed 3 regulates the tumor growth factor-β signaling pathway via the formation of RNA-DNA triplex structures (11).…”